Trial Profile
A Study on Safety, Tolerability and Pharmacokinetics of Ritonavir-boosted Danoprevir in Single and Multiple Doses in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2017
Price :
$35
*
At a glance
- Drugs Danoprevir (Primary) ; Ritonavir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Ascletis
- 18 Jan 2017 New trial record